Pediatric Blood & Cancer, 1545-5017

Journal

More filtering options
  1. 1989
  2. Radio-iodobenzylguanidine scintigraphy of neuroblastoma: conflicting results, when compared with standard investigations

    Schmiegelow, K., Simes, M. A., Agertoft, L., Berglund, G., Storm-Mathisen, I., Andreassen, M., Salmi, T. T., Nygard, R., Thomas Wiebe, Kreuger, A. & Hayder, S., 1989, In : Medical and Pediatric Oncology. 17, 2, p. 126-130

    Research output: Contribution to journalArticle

  3. 1990
  4. Letter to the editor: "Role of chemotherapy in pediatric pulmonary blastoma" by Ozkaynak et al., 1990

    Békássy, A., Hägerstrand, I., Henrikson, H., Garwicz, S. & Thomas Wiebe, 1990, In : Medical and Pediatric Oncology. 18, 5, p. 359-359

    Research output: Contribution to journalLetter

  5. Pharmacokinetics of cytosine arabinoside in cerebrospinal fluid and of its metabolite in leukemic cells

    Békássy, A., Liliemark, J., Garwicz, S., Thomas Wiebe, Gulliksson, H. & Peterson, C., 1990, In : Medical and Pediatric Oncology. 18, 2, p. 136-142

    Research output: Contribution to journalArticle

  6. 1992
  7. Hepatocellular carcinoma associated with arteriohepatic dysplasia in a 4-year-old girl

    Békássy, A., Garwicz, S., Thomas Wiebe, Hägerstrand, I. & Jensen, O. A., 1992, In : Medical and Pediatric Oncology. 20, 1, p. 78-83

    Research output: Contribution to journalArticle

  8. 1997
  9. Letter to the editor: Uncertain role of high dose chemotherapy with autologous stem cell support in pediatric pleuro-pulmonary blastoma (PPB)

    Békássy, A., Garwicz, S., Thomas Wiebe & Hägerstrand, I., 1997, In : Medical and Pediatric Oncology. 28, 1, p. 75-76

    Research output: Contribution to journalLetter

  10. 1999
  11. Cytogenetic aberrations in Ewing sarcoma: are secondary changes associated with clinical outcome?

    Kullendorff, C-M., Fredrik Mertens, Donner, M., Thomas Wiebe, Åkerman, M. & Nils Mandahl, 1999, In : Medical and Pediatric Oncology. 32, 2, p. 79-83

    Research output: Contribution to journalArticle

  12. Dosimetry and growth hormone deficiency following cranial irradiation of childhood brain tumors

    Schmiegelow, M., Lassen, S., Lars Weber, Skovgaard-Poulsen, H., Hertz, H. & Müller, J., 1999, In : Medical and Pediatric Oncology. 33, 6, p. 564-571

    Research output: Contribution to journalArticle

  13. 2000
  14. 2002
  15. Pharmacokinetics of doxorubicin in children with acute lymphoblastic leukemia: Multi-institutional collaborative study

    Frost, BM., Eksborg, S., Bjork, O., Abrahamsson, J., Behrendtz, M., Anders Castor, Forestier, E. & Lonnerholm, G., 2002, In : Medical and Pediatric Oncology. 38, 5, p. 329-337

    Research output: Contribution to journalArticle

  16. 2004
  17. Childhood cancer: the family experience

    Björk, M. B. & Inger Hallström, 2004, In : Pediatric Blood & Cancer. 43, 4, p. 336

    Research output: Contribution to journalPublished meeting abstract

  18. 2005
  19. Children with cancer and their families – a longitudinal approach

    Björk, M., Thomas Wiebe & Inger Hallström, 2005, In : Pediatric Blood & Cancer. 45, p. 562-563 2 p.

    Research output: Contribution to journalPublished meeting abstract

  20. Development of an international pediatric oncology research network

    Woodgate, R., Clarke, J., Gibson, F., Inger Hallström, Kline, N., Monterosso, L., von Essen, L. & Wettergren, L., 2005, In : Pediatric Blood & Cancer. 45, 4, p. 400

    Research output: Contribution to journalPublished meeting abstract

  21. Immunosuppression with ALG and CsA is first line treatment in children with SAA lacking an HLA identical sibling.

    Békássy, A., Locasciulli, A., Marsh, J. C. W., Socié, G., Fuehrer, M. & Passweg, J., 2005, In : Pediatric Blood & Cancer. 45, 3, p. 359-360

    Research output: Contribution to journalLetter

  22. Needs of children with cancer during their initial hospitalization

    Björk, M., Nordström, B. & Inger Hallström, 2005, In : Pediatric Blood & Cancer. 45, 4, p. 564

    Research output: Contribution to journalArticle

  23. Needs of young children with cancer during their initial hospitalization.

    Björk, M., Nordström, B. & Inger Hallström, 2005, In : Pediatric Blood & Cancer. 45, 4, p. 564

    Research output: Contribution to journalPublished meeting abstract

  24. 2006
  25. Development of a disease-specific quality of life questionnaire for children & adolescents with idiopathic thrombocytopenic purpura (ITP-QoL)

    von Mackensen, S., Nilsson, C., Jankovic, M., Mirra, N., D'Angelo, E., Borkhardt, A. & Rolf Ljung, 2006, In : Pediatric Blood & Cancer. 47, Suppl.5, p. 688-691

    Research output: Contribution to journalArticle

  26. Studies of chronic ITP in children and adolescents.

    Nilsson, C., Ulf Tedgård & Rolf Ljung, 2006, In : Pediatric Blood & Cancer. 47, S5, p. 660-661

    Research output: Contribution to journalArticle

  27. 2007
  28. Mortality experiences among 15+ year survivors of childhood and adolescence cancers.

    Möller, T. & Garwicz, S., 2007, In : Pediatric Blood & Cancer. 48, 3, p. 363-363

    Research output: Contribution to journalLetter

  29. Successful treatment of a child with t(15;19)-positive tumor.

    Fredrik Mertens, Thomas Wiebe, Adlercreutz, C., Nils Mandahl & French, C. A., 2007, In : Pediatric Blood & Cancer. 49, p. 1015-1017

    Research output: Contribution to journalArticle

  30. 2008
  31. Experiences and needs of children with cancer and their families in a longitudinal perspective

    Björk, M., Thomas Wiebe & Inger Hallström, 2008, In : Pediatric Blood & Cancer. 49, 4: Suppl, p. 557

    Research output: Contribution to journalPublished meeting abstract

  32. 2009
  33. Biomarkers in the Cerebrospinal Fluid and Neurodegeneration in Langerhans Cell Histiocytosis

    Gavhed, D., Akefeldt, S. O., Osterlundh, G., Laurencikas, E., Lars Hjorth, Blennow, K., Rosengren, L. & Henter, J-I., 2009, In : Pediatric Blood & Cancer. 53, 7, p. 1264-1270

    Research output: Contribution to journalArticle

  34. Health Status at Long-Term Follow-Up in Patients Treated for Extremity Localized Ewing Sarcoma or Osteosarcoma: A Scandinavian Sarcoma Group Study

    Aksnes, L. H., Bauer, H. C. F., Dahl, A. A., Fossa, S. D., Lars Hjorth, Jebsen, N., Lernedal, H. & Hall, K. S., 2009, In : Pediatric Blood & Cancer. 53, 1, p. 84-89

    Research output: Contribution to journalArticle

  35. Individualized 6-Mercaptopurine Increments During Consolidation Treatment Of Lower Risk Childhood All

    Frandsen, T., Abrahamsson, J., Lausen, B., Vettenranta, K., Heyman, M., Behrentz, M., Anders Castor & Schmiegelow, K., 2009, In : Pediatric Blood & Cancer. 53, 5, p. 726-727

    Research output: Contribution to journalPublished meeting abstract

  36. Low frequency of EWSR1 rearrangements in neoplasms classified as high-risk wilms tumors.

    Ildiko Frigyesi, Möller, E., Stewénius, Y., Isaksson, M., Bras, J., Alumets, J., Ingrid Øra, Sandstedt, B. & David Gisselsson Nord, 2009, In : Pediatric Blood & Cancer. 53, p. 683-684

    Research output: Contribution to journalArticle

  37. Magnetic Resonance Imaging in Children can more Children go through the Examination without Sedation?

    Erna Törnqvist, Månsson, Å. & Hallstöm, I., 2009, In : Pediatric Blood & Cancer. 53, 5, p. 743-743

    Research output: Contribution to journalPublished meeting abstract

Previous 1 2 3 Next